Cargando…

Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks

BACKGROUND: An increasing number of studies support the presence of stem-like cells in human malignancies. These cells are primarily responsible for tumor initiation and thus considered as a potential target to eradicate tumors. CD133 has been identified as an important cell surface marker to enrich...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabu, Kouichi, Kimura, Taichi, Sasai, Ken, Wang, Lei, Bizen, Norihisa, Nishihara, Hiroshi, Taga, Tetsuya, Tanaka, Shinya
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836276/ https://www.ncbi.nlm.nih.gov/pubmed/20167130 http://dx.doi.org/10.1186/1476-4598-9-39

Ejemplares similares

Glioma progression and recurrence involving maintenance and expansion strategies of glioma stem cells by organizing self-advantageous niche microenvironments
por: Taga, Tetsuya, et al.
Publicado: (2020)

Cancer ego-system in glioma: an iron-replenishing niche network systemically self-organized by cancer stem cells
por: Tabu, Kouichi, et al.
Publicado: (2022)

O(6)-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies
por: Sasai, Ken, et al.
Publicado: (2007)

Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes
por: Murota, Yoshitaka, et al.
Publicado: (2016)

Cancer Stem Cell-Associated Immune Microenvironment in Recurrent Glioblastomas
por: Murota, Yoshitaka, et al.
Publicado: (2022)

Therapy-resistant nature of cancer stem cells in view of iron metabolism
por: Wang, Wenqian, et al.
Publicado: (2022)

Impact of ERK5 on the Hallmarks of Cancer
por: Stecca, Barbara, et al.
Publicado: (2019)

A niche-mimicking polymer hydrogel-based approach to identify molecular targets for tackling human pancreatic cancer stem cells
por: Murota, Yoshitaka, et al.
Publicado: (2023)

Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers
por: Scharpf, Robert B., et al.
Publicado: (2022)

Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation
por: Wang, Wenqian, et al.
Publicado: (2017)

RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball
por: Herrero, Ana, et al.
Publicado: (2021)

Aberrant Alternative Splicing Is Another Hallmark of Cancer
por: Ladomery, Michael
Publicado: (2013)

Endoplasmic Reticulum-Localized Transmembrane Protein Dpy19L1 Is Required for Neurite Outgrowth
por: Watanabe, Keisuke, et al.
Publicado: (2016)

A computationally engineered RAS rheostat reveals RAS/ERK signaling dynamics
por: Rose, John C., et al.
Publicado: (2016)

CXCL3 contributes to CD133(+) CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation
por: Zhang, Lin, et al.
Publicado: (2016)

Prognostic Implication of Histological Oligodendroglial Tumor Component: Clinicopathological Analysis of 111 Cases of Malignant Gliomas
por: Kanno, Hiromi, et al.
Publicado: (2012)

Circadian clock-controlled diurnal oscillation of Ras/ERK signaling in mouse liver
por: TSUCHIYA, Yoshiki, et al.
Publicado: (2013)

CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
por: Ding, Qiang, et al.
Publicado: (2014)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
por: Farina, Antonietta Rosella, et al.
Publicado: (2020)

Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
por: Lippert, Timothy P., et al.
Publicado: (2021)

Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS/ERK pathway
por: Inoue, Miki, et al.
Publicado: (2022)

Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells
por: Matsumoto, Ryuji, et al.
Publicado: (2016)

Ras–ERK Signaling in Behavior: Old Questions and New Perspectives
por: Fasano, Stefania, et al.
Publicado: (2011)

YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
por: Suzuki, Izumi, et al.
Publicado: (2021)

A Clinicopathological Analysis of Six Autopsy Cases of Sudden Unexpected Death due to Infectious Aortitis in Patients with Aortic Tears
por: Ishikawa, Marin, et al.
Publicado: (2018)

CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2022)

Mulberry polyphenol extracts attenuated senescence through inhibition of Ras/ERK via promoting Ras degradation in VSMC
por: Chen, Ching-Pei, et al.
Publicado: (2022)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1
por: Minami, Yusuke, et al.
Publicado: (2014)

Organization of self-advantageous niche by neural stem/progenitor cells during development via autocrine VEGF-A under hypoxia
por: Kashiwagi, Taichi, et al.
Publicado: (2023)

The metastasis suppressor Nm23 as a modulator of Ras/ERK signaling
por: Takács-Vellai, Krisztina
Publicado: (2014)

The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity
por: Slack, Cathy, et al.
Publicado: (2015)

Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs
por: Yue, Jingyin, et al.
Publicado: (2017)

Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras
por: Frodyma, Danielle, et al.
Publicado: (2017)

Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2018)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
por: Gillies, Taryn E, et al.
Publicado: (2020)

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
por: Degirmenci, Ufuk, et al.
Publicado: (2020)

Correction for: CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2023)

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially
por: Vantaggiato, Chiara, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_r4s0ta42nhlvdr8gq2eos09pm8